This technology is an artificial intelligence system for eye disease detection that is trained using eye movements of clinical and medical experts as they view ophthalmic images.
Diagnosis of glaucoma and age-related macular degeneration requires timely assessment by medical experts while also lacking a gold standard. Artificial intelligence (AI) systems can aid diagnosis, but the lack of interpretability and expert-level decision-making hinders their implementation in the clinic. There are currently no AI systems that combine the domain expertise of medical experts to engineer a system for enhanced glaucoma detection.
This technology is a more accurate and interpretable artificial intelligence (AI) system for eye disease detection that is trained using eye-tracking data from medical professionals during the analysis of patient eye imaging. The algorithm is developed using eye tracking equipment on experts which will be analyzed and integrated with the classification and identification of glaucoma. Using visual transformers, contrastive learning, and other machine learning methods, this system develops a sense of eye-movement-informed attention and enables weakly-supervised learning of eye disease diagnosis. This system can guide medical trainees and experts in analyzing eye images to reduce diagnostic errors.
Patent Pending
IR CU23260
Licensing Contact: Dovina Qu